Actinium Pharmaceuticals Inc (ATNM) — Long-term Investment Intensity
Actinium Pharmaceuticals Inc (ATNM) has a Long-term Investment Intensity of 0.2% as of June 2019. Long-term investments of $49.86K represent 0.2% of total assets of $21.82 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of Actinium Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Actinium Pharmaceuticals Inc Long-term Investment Intensity (2016–2018)
This chart shows how Actinium Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of June 2019, the intensity stands at 0.2%, reflecting long-term investments of $49.86K against total assets of $21.82 Million USD. Explore ATNM debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Actinium Pharmaceuticals Inc (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for Actinium Pharmaceuticals Inc from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Actinium Pharmaceuticals Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.3% | $49.86K | $14.89 Million | ▲ +0.1 pp |
| 2017 | 0.3% | $49.86K | $18.34 Million | ▲ +0.1 pp |
| 2016 | 0.2% | $49.86K | $22.53 Million | — |